Jeff Clark co-founded The Aurora Funds with Scott
Albert in 1994. He works primarily with Aurora's life
sciences portfolio. He pulls from his strategic
planning and operational experience to help these
companies create or refine business plans, build solid
management teams, develop strategic partnerships and
secure key customers.
Jeff currently serves on the boards of several of
Aurora's life science portfolio companies, including
Aldagen, Argos Therapeutics, Hyperbranch Medical
Technology, Metabolon, Regado Biosciences and Xsira
Pharmaceuticals assisting in the strategic direction
of each.
Prior to forming Aurora, Jeff spent thirteen years
working in development and external affairs for Duke
University (including Duke Comprehensive Cancer
Center, Duke Medical Center and the School of
Engineering). Through Aurora, he hoped to close the
gap between local universities and the venture capital
community to facilitate the growth of life science
companies.
Jeff maintains strong ties to the RTP community,
serving as past Chairman of the Board of North
Carolina's Council for Entrepreneurial Development,
the Board of Overseers of the Duke Comprehensive
Cancer Center and the Board of Directors for TROSA and
the Choral Society of Durham. Jeff is also Founding
Chair of NC EntrePAC and associated entities.
Jeff holds a Bachelor of Science in Mechanical
Engineering from Duke University and a MBA from the
Fuqua School of Business at Duke University.
|